
J&J and Colgate pay $4.8 million each to woman in California
pharmafile | June 13, 2019 | News story | Business Services, Medical Communications | Cancer, J&J, JJ, lawsuit, pharma, talc
A California court has said Johnson & Johnson and Colgate-Palmolive must pay a total of nearly $10 million to a woman who developed cancer.
Colgate and J&J must pay Patricia Schmitz $4.8 million in damages each. The ruling comes after Schmitz developed mesothelioma after using J&J’s Baby Powder and Colgate’s Cashmere Bouquet. Schmitz was not awarded punitive damages.
The ruling comes as another setback for healthcare conglomerate J&J who face more than 13,000 talc-related lawsuits. J&J was just two weeks ago ordered to pay $300 million in punitive damages to a woman in New York who developed cancer after using the firm’s products.
Jurors in South Carolina cleared the company of liability in a different case on the same day.
“We will pursue an appeal because Johnson’s Baby Powder does not contain asbestos or cause cancer, as supported by decades of independent clinical evidence,” a J&J spokesperson said.
“There were serious procedural and evidentiary errors in the proceeding that required us to move for mistrial on multiple occasions and we believe provide strong grounds for appeal.”
Louis Goss
Related Content

LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence
LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of …

Central nervous system cancer metastases – the evolution of diagnostics and treatment
The current forms of immunotherapy, how T cell therapy works and what the future holds

BioMed X and Servier launch Europe’s first XSeed Labs to advance AI-powered antibody design
BioMed X and Servier have announced the launch of Europe’s first XSeed Labs research project, …






